| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -15,178 | -9,512 |
| Purchases of property and equipment | 82 | 70 |
| Net cash used in investing activities | -82 | -70 |
| Proceeds from issuance of series h convertible preferred stock | 0 | - |
| Proceeds from ipo, net of commissions | 26,557 | - |
| Payment of deferred ipo offering costs | 3,184 | - |
| Proceeds from promissory note issuance | 1,000 | 1,000 |
| Repayment of promissory note | 1,000 | - |
| Proceeds from exercises of options on common stock and warrants | 216 | 202 |
| Net cash provided by financing activities | 23,589 | 1,202 |
| Net increase (decrease) in cash and cash equivalents | 8,329 | -8,380 |
| Effect of exchange rate changes on cash | 139 | - |
| Cash and cash equivalents at beginning of period | 9,319 | - |
| Cash and cash equivalents at end of period | 17,787 | - |
CapsoVision, Inc (CV)
CapsoVision, Inc (CV)